The company has a total debt of around Rs 3,100 crore. Set up in 1992 as an export-oriented unit, Orchid Chemicals Pharmaceuticals currently has presence across segments such as anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products.
Subscribe To Our Free Newsletter |